Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent.

Acoustically activated submicron droplets of liquid perfluorocarbon are investigated as a new class of ultrasound contrast agent. In the liquid state, intravascular droplets can extravasate within tumours. Activation is then accomplished by using bursts of ultrasound to vaporize the droplets. We use acoustical and optical techniques to assess the characteristics of vaporized droplets and the resulting microbubbles in vitro, including size, conversion threshold, echogenicity and nonlinearity. Under exposure to single 5-50 cycle bursts of ultrasound at 7.5 MHz and mechanical index <1.0, droplets with mean diameter of 400 nm convert into microbubbles with mean diameter of 1.4 μm at 1 ms after vaporization, expanding to 5.6 μm by 1 s. The growth of microbubbles produced by vaporization causes a characteristic time-dependent increase in linear and nonlinear echogenicity, enabling selective detection with conventional bubble-specific imaging. These results suggest that submicron perfluorocarbon droplets, activated in situ, may be a candidate for an extravascular ultrasound contrast agent.

[1]  C. Church,et al.  Spontaneous homogeneous nucleation, inertial cavitation and the safety of diagnostic ultrasound. , 2002, Ultrasound in medicine & biology.

[2]  S. Umemura,et al.  Cavitation assisted HIFU with phase-change nano droplet , 2008, 2008 IEEE Ultrasonics Symposium.

[3]  Kullervo Hynynen,et al.  Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. , 2003, Ultrasound in medicine & biology.

[4]  P. Carson,et al.  The role of inertial cavitation in acoustic droplet vaporization , 2008, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[5]  Oliver D Kripfgans,et al.  Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion. , 2010, Ultrasound in medicine & biology.

[6]  D. Christensen,et al.  Microbubble Generation in Phase-Shift Nanoemulsions used as Anticancer Drug Carriers. , 2009, Bubble science engineering and technology.

[7]  E. J. Barber,et al.  Vapor Pressures of Perfluoropentanes , 1956 .

[8]  P. Carson,et al.  On the acoustic vaporization of micrometer-sized droplets. , 2004, The Journal of the Acoustical Society of America.

[9]  Olivier Couture,et al.  Investigating perfluorohexane particles with high-frequency ultrasound. , 2006, Ultrasound in medicine & biology.

[10]  S. Umemura,et al.  1F-3 Site-Specific Contrast Imaging with Locally Induced Microbubbles from Liquid Precursors , 2006, 2006 IEEE Ultrasonics Symposium.

[11]  O. Kripfgans,et al.  Acoustic droplet vaporization threshold: effects of pulse duration and contrast agent , 2007, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[12]  J B Fowlkes,et al.  Acoustic droplet vaporization for therapeutic and diagnostic applications. , 2000, Ultrasound in medicine & biology.

[13]  K. Ferrara,et al.  Transmitted ultrasound pressure variation in micro blood vessel phantoms. , 2008, Ultrasound in medicine & biology.

[14]  I. Marrucho,et al.  Solubility of oxygen in liquid perfluorocarbons , 2004 .

[15]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[16]  T. Kim,et al.  Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. , 2007, AJR. American journal of roentgenology.

[17]  Stephanie R Wilson,et al.  Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images. , 2007, Radiology.

[18]  B B Gosink,et al.  Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. , 1982, Radiology.

[19]  R. Karshafian,et al.  Quantification of flow using ultrasound and microbubbles: a disruption replenishment model based on physical principles. , 2009, Ultrasound in medicine & biology.

[20]  T. Porter,et al.  An in vitro study of a phase-shift nanoemulsion: a potential nucleation agent for bubble-enhanced HIFU tumor ablation. , 2010, Ultrasound in medicine & biology.

[21]  K. Hynynen,et al.  Nanoparticle-loaded perfluorocarbon droplets for imaging and therapy , 2009, 2009 IEEE International Ultrasonics Symposium.

[22]  Kullervo Hynynen,et al.  In vitro characterization of perfluorocarbon droplets for focused ultrasound therapy , 2010, Physics in medicine and biology.

[23]  P. Burns,et al.  Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents , 1997, 1997 IEEE Ultrasonics Symposium Proceedings. An International Symposium (Cat. No.97CH36118).

[24]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[25]  D. Christensen,et al.  Cavitation properties of block copolymer stabilized phase-shift nanoemulsions used as drug carriers. , 2010, Ultrasound in medicine & biology.

[26]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Harald Becher,et al.  Handbook of Contrast Echocardiography , 2000, Springer Berlin Heidelberg.